Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Uterine Neoplasms × pembrolizumab × Clear all

Phase

Phase 1/2 3 Phase 2 2 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 106 Melanoma 82 Neoplasms 70 Colorectal Neoplasms 56 Squamous Cell Carcinoma of Head and Neck 53 Neoplasm Metastasis 49 Triple Negative Breast Neoplasms 43 Carcinoma, Renal Cell 42 Breast Neoplasms 37 Lung Neoplasms 32 Ovarian Neoplasms 30 Pancreatic Neoplasms 28 Urinary Bladder Neoplasms 24 Head and Neck Neoplasms 24 Stomach Neoplasms 23 Carcinoma, Transitional Cell 22 Parkinson Disease 4, Autosomal Dominant Lewy Body 21 Endometrial Neoplasms 20 Uterine Cervical Neoplasms 19 Carcinoma, Hepatocellular 15 Esophageal Neoplasms 14 Lymphoma 13 Recurrence 12 Prostatic Neoplasms 12 Carcinoma, Squamous Cell 12 Kidney Neoplasms 11 Sarcoma 9 Lymphoma, Large B-Cell, Diffuse 9 Cholangiocarcinoma 9 Solid Tumor 8

Interventions

Paclitaxel 2 temsirolimus 1 pembrolizumab 1 dehydroftorafur 1 Topotecan 1 Platinum 1 Oxaliplatin 1 OSI 930 1 Mitozytrex 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Loperamide 1 Leucovorin 1 Irinotecan 1 Hyperthermic Intraperitoneal Chemotherapy 1 Gemcitabine 1 Fulvestrant 1 Fluorouracil 1 Fluorodeoxyglucose F18 1 Fecal Microbiota Transplantation 1 FAPI-46 1 Doxorubicin 1 Cisplatin 1 Carboplatin 1 Bortezomib 1 Biopsy 1 4-hydroxy-N-desmethyltamoxifen 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04262089 2023-12-05

PAM

University Medical Center Groningen

Phase 1 Completed

Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡